Abbey Lara, MD

Associate Professor, Medicine-Pulmonary Sciences & Critical Care


FacultyPhoto
Medical School
  • MD, University of Wisconsin School of Medicine and Public Health (2001)
Undergraduate School
  • BS, University of California–San Diego (CA) (1997)
Residency
  • Cleveland Clinic Foundation Program, Internal Medicine (2004)
Fellowships
  • University of Colorado, Pulmonary Disease and Critical Care Medicine (2008)
Languages
English
Department
Medicine-Pulmonary Sciences & Critical Care

Publications

  • Alterations of the arginine metabolome in asthma. Lara A, Khatri SB, Wang Z, Comhair SA, Xu W, Dweik RA, Bodine M, Levison BS, Hammel J, Bleecker E, Busse W, Calhoun WJ, Castro M, Chung KF, Curran-Everett D, Gaston B, Israel E, Jarjour N, Moore W, Peters SP, Teague WG, Wenzel S, Hazen SL, Erzurum SC; National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Am J Respir Crit Care Med. 2008 Oct 1;178(7):673-81. Epub 2008 Jul 17
  • Respiratory Failure. Just the Facts:Hospital Medicine.
  • Diffuse Alveolar Hemorhage in Interstitial Lung Disease. 5th Edition.
  • Diffuse Alveolar Hemorrhage, Chest
  • A Detailed Evaluation of Acute Respiratory Decline in Patients with Fibrotic Lung Disease: Aetiology and Outcomes in Respirology
  • Resident lung mesenchymal stem cells attenuate bleomycin induced pulmonary fibrosis via modulation of the T cell response
  • Jun D, Carat C, West J, Thorn N, Chow K, Cleaver T, Sullivan T, Childs C, Torchia E, Shade T, Nozik-Grayck E, Malkowski S, Lara A, Klemm D, Rojas M, Wagner Jr DH, Majka S. Resident lung mesenchymal stem cells attenuate bleomycin induced pulmonary fibrosis via modulation of the T cell response. Stem Cells 2011; 29:725-735
  • Rendte EF, Jacobsen KM, Solomon JJ, Lara AR, Faubel S, Keith RC, Henson PM, Downey GP, Riches DW. Age and Gender Dimorphisms Contribute to the Severity of Bleomycin-Induced Lung Injury in Fibrosis. Am J Physio Lung Cell Mol Physiol 2011 Oct;301(4) L510-8
  • Nakano Y, Yang IV, Walts AD, Watson AM, Helling BA, Fletcher AA, Lara AR, Schwarz MI, Evans CM, Schwartz DA. MUC5B Promoter Variant rs35705950 Affects MUC5B Expression in the Distal Airways in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2016 Feb 15;193(4):464-6. PubMed PMID: 26871673
  • Lara A, Schwarz M. Pirfenidone: is it tolerable?. BMJ Open Respir Res. 2016;3(1):e000124. PubMed PMID: 26835136
  • Lara AR, Cosgrove GP, Tuder RM, Henson PM. Changes In Blood Vessel Morphometry Are Associated With Disease Severity In Interstitial Lung Diseases. American Thoracic Society, Internatioin Conference San Francisco 2012
  • Laub M, Fraser R, Kurche J, Lara A, Kiser TH, Reynolds PM. Use of a Cholestyramine Washout in a Patient With Septic Shock on Leflunomide Therapy: A Case Report and Review of the Literature. J Intensive Care Med. 2015 Oct 6. [Epub ahead of print] PubMed PMID: 26446104
  • Diffuse Alveolar Hemorrhage Syndromes, Interstitial Lung Disease in the ICU. American Thoracic Society, International Conference, Denver 2011
  • Tuder RM, Lara AR, Thannickal VJ. Lactate, a novel trigger of Transforming Growth Factor-â Activation in Idiopathic Pulmonary Fibrosis. Am. J. Respir. Crit Care Med. 2012;186:699. PMID:23071184
  • Nakano Y, Yang IV, Walts AD, Watson AM, Helling BA, Fletcher AA, Lara AR, Schwarz MI, Evans CM, Schwartz DA. MUC5B Promoter Variant rs35705950 Affects MUC5B Expression in the Distal Airways in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2016 Feb 15;193(4):464-6. PubMed PMID: 26871673
  • Lara AR, Cosgrove GP, Janssen WJ, Huie TJ, Burnham EL, Heinz DE, Curran-Everett D, Sahin H, Schwarz MI, Cool CD, Groshong SD, Geraci MW, Tuder RM, Hyde DM, Henson PM. Increased Lymphatic Vessel Length is Associated with the Fibroblast Reticulum and Disease Severity in Usual Interstitial Pneumonia and Non-Specific Interstitial Pneumonia. Chest 2012;142(6):1569. PMID: 22797508
  • Lara A, Schwarz M. Pirfenidone: is it tolerable?. BMJ Open Respir Res. 2016 Jan 12;3(1):e000124. PubMed PMID: 26835136
  • Increased lymphatic vessel length is associated with the fibroblast reticulum and disease severity in UIP and NSIP
  • Changes in blood vessel morphometry are associated with disease severity in Interstitial Lung Diseases
  • Laub M, Fraser R, Kurche J, Lara A, Kiser TH, Reynolds PM. Use of a Cholestyramine Washout in a Patient With Septic Shock on Leflunomide Therapy: A Case Report and Review of the Literature. J Intensive Care Med. 2016 Jul;31(6):412-4. PubMed PMID: 26446104
  • Treatment with lymphangiogenic blocking antibodies abrogates inflammation in a bleomycin model of pulmonary fibrosis
  • Xu W, Comhair SAA, Janocha AJ, Lara A, Mavrakis LA, Bennett CD, Kalhan SC, Erzurum SC. Arginine metabolic endotypes related to asthma severity. PLoS One. 2017;12(8):e0183066. PubMed PMID: 28797075
  • 1. Lara AR, Environmental Pulmonary Disease. The Merck Manuals. 2017. Kenilworth, NJ. Update pending final website approval. http://www.merckmanuals.com/professional/pulmonary-disorders/environmental-pulmonary-diseases/overview-of-environmental-pulmonary-disease
  • The Merck Manuals. 2018. Kenilworth, NJ. https://www.merckmanuals.com/professional/pulmonary-disorders/environmental-pulmonary-diseases/overview-of-environmental-pulmonary-disease

Practice Locations

UCHealth Pulmonology Clinic - Anschutz Medical Campus
1635 Aurora Ct
7th Floor
Aurora, CO 80045
720-848-0748

Hospital Affiliation
  • University of Colorado Hospital

Specialty Information

Specialties
  • Pulmonary Disease and Critical Care Medicine, Board Certification
Conditions & Treatments
  • Lungs and Breathing